Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06540287

Molecular Optimization Via Exercise (MOVE)

An Observational Study of Aging Biomarkers in Older Elite Athletes Compared to Non-exercising Healthy Older Adults.

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Buck Institute for Research on Aging · Academic / Other
Sex
All
Age
65 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function testing and body composition.

Detailed description

The study will enroll a total of 80 subjects-20 of each gender for each cohort. Participation in the study involves 3 visits that must take place within 12 weeks. Optional l follow up visits may be completed at 12- and 24- months after completion of the main study. The first visit is a screening and enrollment visit. At this visit, informed consent will be obtained and a detailed medical history, screening blood sample collected, and physical assessment will be performed (including, but not limited to vital signs, resting ECG, body composition). Additionally, an exercise history interview will be performed to assess for cohort eligibility. Participants will be familiarized with testing equipment during the screening visit and will perform the Astrand-Rhyming submaximal bicycle test. A short physical function testing battery will be performed, including the short physical performance battery, 6 minute walk test, grip strength, 1 rep max leg press, and leg press fatigue testing. The second visit will include maximal exercise testing, quality of life assessment, and cognitive function testing. Participants will be allocated into their cohort at this visit. The third visit will include thigh muscle sample collection via needle biopsy and blood sample collection.

Conditions

Interventions

TypeNameDescription
OTHERObservationalNo intervention

Timeline

Start date
2024-09-19
Primary completion
2026-12-01
Completion
2027-05-01
First posted
2024-08-06
Last updated
2024-10-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06540287. Inclusion in this directory is not an endorsement.